Xenitra logs strong first-week sales in tokenised EZZ product launch

AuMake Ltd. ( (AU:XEN) ) has shared an update.

Xenitra has launched the EZZ range of health products on its OPAL tokenised sales platform, recording more than $100,000 in sales to over 20 distributors in the first week under a four-year, $10 million global distribution agreement. The company says margins on these tokenised sales will significantly exceed the contracted offtake value, as OPAL-linked purchases automatically issue utility tokens that feed a reserve-backed rewards program designed to boost customer engagement, loyalty and repeat purchases.

Management positions OPAL as a scalable, self-reinforcing commercial flywheel, where each sale allocates part of the margin into a token reserve while token redemptions permanently reduce supply, potentially increasing perceived value for users over time. With multiple new brands slated to join the platform in coming months and the EZZ launch event drawing more than 100 distributors and 12,000 livestream viewers, the model aims to extend Xenitra’s reach across brands and markets and strengthen its position at the intersection of FMCG distribution and blockchain-enabled loyalty.

More about AuMake Ltd.

Xenitra Limited is an Asia-focused company pioneering a blockchain-based, tokenised sales ecosystem for fast-moving consumer goods. Through its OPAL real world asset token platform, the business tokenises product purchases to create a rewards-driven distribution model, and holds exclusive global distribution rights for EZZ Life Sciences products within this ecosystem.

Current Market Cap: A$11.59M

For an in-depth examination of XEN stock, go to TipRanks’ Overview page.